Ameritas Investment Partners’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.14K | Buy |
+349
| New | +$8.14K | ﹤0.01% | 3033 |
|
|
2024
Q2 | – | Sell |
-92
| Closed | -$3.01K | – | 3255 |
|
|
2024
Q1 | $3.01K | Hold |
92
| – | – | ﹤0.01% | 3000 |
|
|
2023
Q4 | $2.46K | Hold |
92
| – | – | ﹤0.01% | 3052 |
|
|
2023
Q3 | $5.56K | Hold |
92
| – | – | ﹤0.01% | 2971 |
|
|
2023
Q2 | $9.37K | Hold |
92
| – | – | ﹤0.01% | 2925 |
|
|
2023
Q1 | $16.3K | Hold |
92
| – | – | ﹤0.01% | 2536 |
|
|
2022
Q4 | $39.1K | Hold |
92
| – | – | ﹤0.01% | 2229 |
|
|
2022
Q3 | $30K | Hold |
92
| – | – | ﹤0.01% | 2309 |
|
|
2022
Q2 | $30K | Hold |
92
| – | – | ﹤0.01% | 2325 |
|
|
2022
Q1 | $40K | Hold |
92
| – | – | ﹤0.01% | 2196 |
|
|
2021
Q4 | $40K | Hold |
92
| – | – | ﹤0.01% | 2284 |
|
|
2021
Q3 | $51K | Hold |
92
| – | – | ﹤0.01% | 2151 |
|
|
2021
Q2 | $47K | Hold |
92
| – | – | ﹤0.01% | 2232 |
|
|
2021
Q1 | $72K | Hold |
92
| – | – | ﹤0.01% | 1863 |
|
|
2020
Q4 | $50K | Hold |
92
| – | – | ﹤0.01% | 1997 |
|
|
2020
Q3 | $42K | Hold |
92
| – | – | ﹤0.01% | 1947 |
|
|
2020
Q2 | $57K | Hold |
92
| – | – | ﹤0.01% | 1754 |
|
|
2020
Q1 | $44K | Hold |
92
| – | – | ﹤0.01% | 1744 |
|
|
2019
Q4 | $53K | Hold |
92
| – | – | ﹤0.01% | 1886 |
|
|
2019
Q3 | $61K | Buy |
92
+15
| +19% | +$9.95K | ﹤0.01% | 1767 |
|
|
2019
Q2 | $59K | Hold |
77
| – | – | ﹤0.01% | 1833 |
|
|
2019
Q1 | $54K | Hold |
77
| – | – | ﹤0.01% | 1854 |
|
|
2018
Q4 | $36K | Hold |
77
| – | – | ﹤0.01% | 2000 |
|
|
2018
Q3 | $66K | Buy |
77
+12
| +18% | +$10.3K | ﹤0.01% | 1829 |
|
|
2018
Q2 | $45K | Hold |
65
| – | – | ﹤0.01% | 2060 |
|
|
2018
Q1 | $29K | Hold |
65
| – | – | ﹤0.01% | 2234 |
|
|
2017
Q4 | $29K | Hold |
65
| – | – | ﹤0.01% | 2248 |
|
|
2017
Q3 | $33K | Hold |
65
| – | – | ﹤0.01% | 2135 |
|
|
2017
Q2 | $36K | Buy |
65
+16
| +33% | +$8.86K | ﹤0.01% | 2113 |
|
|
2017
Q1 | $33K | Buy |
+49
| New | +$33K | ﹤0.01% | 2114 |
|